CN Patent

CN105693695A — 一种德拉沙星葡甲胺盐的晶型及其制备方法

Assigned to Chongqing Pharmaceutical Research Institute Co Ltd · Expires 2016-06-22 · 10y expired

What this patent protects

本发明涉及一种德拉沙星葡甲胺盐的新晶型及其制备方法，该晶型的特征在于其X-射线粉末衍射图谱在2θ值约为6.0°、7.9°、9.4°、13.0°、17.1°、19.2°、20.9°、22.0°、23.0°、23.8°、25.4°、26.6°、29.7°的位置对应有特征衍射峰，该晶型具有纯度高、稳定性好等特点。

USPTO Abstract

本发明涉及一种德拉沙星葡甲胺盐的新晶型及其制备方法，该晶型的特征在于其X-射线粉末衍射图谱在2θ值约为6.0°、7.9°、9.4°、13.0°、17.1°、19.2°、20.9°、22.0°、23.0°、23.8°、25.4°、26.6°、29.7°的位置对应有特征衍射峰，该晶型具有纯度高、稳定性好等特点。

Drugs covered by this patent

delafloxacin-meglumine (DELAFLOXACIN MEGLUMINE)

Patent Metadata

Patent number: CN105693695A
Jurisdiction: CN
Classification: —
Expires: 2016-06-22
Drug substance claim: No
Drug product claim: No
Assignee: Chongqing Pharmaceutical Research Institute Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.